4//SEC Filing
Huyett William 4
Accession 0001209191-19-023517
CIK 0001755237other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 7:39 PM ET
Size
15.9 KB
Accession
0001209191-19-023517
Insider Transaction Report
Form 4
Huyett William
DirectorPRESIDENT
Transactions
- Award
Common Stock
2019-04-01+38,327→ 38,327 total - Award
Employee Stock Option (Right to Buy)
2019-04-01+221,349→ 221,349 totalExercise: $16.81Exp: 2028-01-02→ Common Stock (221,349 underlying) - Award
Employee Stock Option (Right to Buy)
2019-04-01+222,002→ 222,002 totalExercise: $14.20Exp: 2029-01-29→ Common Stock (222,002 underlying) - Award
Common Stock
2019-04-01+39,179→ 78,912 total
Footnotes (6)
- [F1]In connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals Inc. ("Ironwood"), the reporting person received a grant of 38,327 restricted stock units, each representing the right to receive a share of Cyclerion common stock, as a result of the adjustment of existing Ironwood restricted stock units held by the reporting person prior to the Separation. The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of common stock on the approximate anniversary of the grant.
- [F2]In connection with the Separation, the reporting person received a grant of 39,179 restricted stock units, each representing the right to receive a share of Cyclerion common stock, as a result of the adjustment of existing Ironwood restricted stock units held by the reporting person prior to the Separation. The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of common stock on the approximate anniversary of the grant.
- [F3]Includes 1,406 shares of Cyclerion common stock received in a pro rata distribution by Ironwood as a result of the Separation.
- [F4]Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation.
- [F5]The option, granted as a new hire award, vested as to 25% of the shares of common stock on December 15, 2019, and 2.08333% of the shares of common stock vest each month thereafter for the next 36 months.
- [F6]The option, granted as an annual performance award, vests as to 2.08333% of the shares of common stock on each monthly anniversary of January 1, 2019.
Issuer
Cyclerion Therapeutics, Inc.
CIK 0001755237
Entity typeother
Related Parties
1- filerCIK 0001723846
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 7:39 PM ET
- Size
- 15.9 KB